The Toronto-Dominion Bank and TD Securities Inc. report beneficial ownership of Stoke Therapeutics, Inc. common stock. Together they report holding 3,183,258 shares of common stock, representing 4.9% of the class. TD Bank has sole voting and dispositive power over 3,173,258 shares, while TD Securities Inc. has sole voting and dispositive power over 10,000 shares. Neither entity reports any shared voting or dispositive power. TD Bank is the sole owner of TD Securities Inc. and may be deemed to hold an indirect interest in the shares held by TD Securities Inc., but disclaims beneficial ownership of those shares except to the extent of its pecuniary interest. The reporting persons state that they are not part of any group with respect to Stoke Therapeutics securities and jointly file this statement under Rule 13d-1(k).
Positive
None.
Negative
None.
Key Figures
Total shares beneficially owned:3,183,258 sharesPercent of class:4.9%TD Bank sole voting/dispositive power:3,173,258 shares+1 more
4 metrics
Total shares beneficially owned3,183,258 sharesCommon stock of Stoke Therapeutics, Inc. reported by TD Bank and TD Securities Inc.
Percent of class4.9%Portion of Stoke Therapeutics common stock class beneficially owned
TD Bank sole voting/dispositive power3,173,258 sharesShares of Stoke Therapeutics over which The Toronto-Dominion Bank has sole power
TD Securities Inc. sole voting/dispositive power10,000 sharesShares of Stoke Therapeutics over which TD Securities Inc. has sole power
Key Terms
beneficially owned, sole voting power, sole dispositive power, pecuniary interest, +2 more
6 terms
beneficially ownedfinancial
"Amount beneficially owned: 3,183,258 TD Bank has the sole power to vote"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting powerfinancial
"TD Bank has the sole power to vote or direct the vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive powerfinancial
"the sole power to dispose or direct the disposition of 3,173,258"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
pecuniary interestfinancial
"disclaims ownership of the shares reported herein by TDSI except to the extent of its pecuniary interest"
Rule 13d-1(k)regulatory
"filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k)"
joint filing agreementregulatory
"Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned"
FAQ
What percentage of Stoke Therapeutics (STOK) shares does The Toronto-Dominion Bank report owning?
The Toronto-Dominion Bank and TD Securities Inc. together report beneficial ownership of 4.9% of Stoke Therapeutics’ common stock, representing 3,183,258 shares in total, according to the Schedule 13G/A amendment filed for STOK.
How many Stoke Therapeutics (STOK) shares are reported by TD Bank versus TD Securities Inc.?
The filing states TD Bank has sole voting and dispositive power over 3,173,258 Stoke Therapeutics shares, while TD Securities Inc. has sole voting and dispositive power over 10,000 shares, for a combined total of 3,183,258 shares.
Does The Toronto-Dominion Bank share voting power over Stoke Therapeutics (STOK) shares?
No. The Schedule 13G/A reports that both The Toronto-Dominion Bank and TD Securities Inc. have sole voting power over their respective STOK shares and report zero shared voting power and zero shared dispositive power.
How does TD Bank describe its ownership of Stoke Therapeutics (STOK) shares held by TD Securities Inc.?
TD Bank may be deemed to hold an indirect interest in STOK shares held by TD Securities Inc. due to its ownership of TDSI, but it disclaims beneficial ownership of those shares except to the extent of its pecuniary interest.
Are TD Bank and TD Securities Inc. acting as a group regarding Stoke Therapeutics (STOK) stock?
The reporting persons expressly state that neither they nor any other person is, for Section 13(d) purposes, acting as a partnership, syndicate, or other group with respect to acquiring, holding, or disposing of Stoke Therapeutics securities.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Stoke Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
86150R107
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
86150R107
1
Names of Reporting Persons
The Toronto-Dominion Bank
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,173,258.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,173,258.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,173,258.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
FI
SCHEDULE 13G
CUSIP Number(s):
86150R107
1
Names of Reporting Persons
TD Securities Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ONTARIO, CANADA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
10,000.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
10,000.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
FI
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Stoke Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
45 WIGGINS AVENUE, BEDFORD, MASSACHUSETTS
01730
Item 2.
(a)
Name of person filing:
The Toronto-Dominion Bank
TD Securities Inc.
(b)
Address or principal business office or, if none, residence:
The principal office address of The Toronto-Dominion Bank ("TD Bank"):
66 Wellington Street West
12th Floor TD Tower
Toronto, Ontario, Canada
M5K 1A2
The principal office address of TD Securities Inc. ("TDSI"):
55 King Street West
TD Tower 12th Floor
Toronto, Ontario, Canada
M5K 1A2
(c)
Citizenship:
The Toronto-Dominion Bank - CANADA (FEDERAL LEVEL)
TD Securities Inc. - ONTARIO, CANADA
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP No.:
86150R107
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
TD Bank - Bank
TDSI - Broker Dealer
Item 4.
Ownership
(a)
Amount beneficially owned:
3,183,258
TD Bank has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 3,173,258 of these shares and
TDSI has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 10,000 of these shares.
This schedule is jointly filed by TD Bank and TDSI. TD Bank is the sole owner of TDSI. TD Bank may be deemed to hold an indirect interest in the shares reported herein by TDSI by virtue of its ownership of TDSI. TD Bank disclaims ownership of the shares reported herein by TDSI except to the extent of its pecuniary interest therein. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
(b)
Percent of class:
4.9 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The Toronto-Dominion Bank - 3,173,258
TD Securities Inc. - 10,000
(ii) Shared power to vote or to direct the vote:
The Toronto-Dominion Bank - 0
TD Securities Inc. - 0
(iii) Sole power to dispose or to direct the disposition of:
The Toronto-Dominion Bank - 3,173,258
TD Securities Inc. - 10,000
(iv) Shared power to dispose or to direct the disposition of:
The Toronto-Dominion Bank - 0
TD Securities Inc. - 0
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
The Toronto-Dominion Bank
Signature:
/s/ Christina Petrou
Name/Title:
Christina Petrou / Executive Vice President & Chief Operating Officer
Date:
08/12/2026
TD Securities Inc.
Signature:
/s/ Jason Chen
Name/Title:
Jason Chen / Senior Vice President - Global Operations and Business Services
Date:
08/12/2026
Exhibit Information
Exhibit I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock of Stoke Therapeutics Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Dated: August 12, 2026
THE TORONTO-DOMINION BANK
By: /s/ Christina Petrou
Title: Executive Vice President & Chief Operating Officer
TD SECURITIES INC.
By: /s/ Jason Chen
Title: Senior Vice President - Global Operations and Business Services
